A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion With Tazorac (Tazarotene) Cream, 0.05% in the Treatment of Plaque Psoriasis
Latest Information Update: 24 Aug 2020
At a glance
- Drugs Tazarotene/ulobetasol (Primary) ; Tazarotene; Tazarotene/ulobetasol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Bausch Health Companies; Valeant Pharmaceuticals International
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 25 Apr 2017 Status changed from recruiting to completed.
- 18 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2016.